These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22515732)

  • 1. Efficacy of preventing hemodialysis catheter infections with citrate lock.
    Silva J; Antunes J; Carvalho T; Ponce P
    Hemodial Int; 2012 Oct; 16(4):545-52. PubMed ID: 22515732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic lock: in vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37 degrees C.
    Battistella M; Walker S; Law S; Lok C
    Hemodial Int; 2009 Jul; 13(3):322-8. PubMed ID: 19493023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia.
    Winnett G; Nolan J; Miller M; Ashman N
    Nephrol Dial Transplant; 2008 Nov; 23(11):3592-8. PubMed ID: 18503094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
    Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
    Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.
    Labriola L; Crott R; Jadoul M
    Nephrol Dial Transplant; 2008 May; 23(5):1666-72. PubMed ID: 18065789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
    Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic lock: in vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37 degrees C.
    Battistella M; Vercaigne LM; Cote D; Lok CE
    Hemodial Int; 2010 Jul; 14(3):322-6. PubMed ID: 20345391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.
    Silva TN; Mendes ML; Abrão JM; Caramori JT; Ponce D
    Int Urol Nephrol; 2013 Oct; 45(5):1405-13. PubMed ID: 23269457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters.
    Meeus G; Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
    Blood Purif; 2005; 23(2):101-5. PubMed ID: 15640601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter-related bacteremia in hemodialysis: which preventive measures to take?
    Silva J; Teixeira e Costa ; Baptista A; Ramos A; Ponce P
    Nephron Clin Pract; 2008; 110(4):c251-7. PubMed ID: 18974657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catheter lock solution--taurolock for prevention of catheter-related bacteremia in hemodialysis patients].
    Geron R; Tanchilevski O; Kristal B
    Harefuah; 2006 Dec; 145(12):881-4, 943. PubMed ID: 17220025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.
    Nori US; Manoharan A; Yee J; Besarab A
    Am J Kidney Dis; 2006 Oct; 48(4):596-605. PubMed ID: 16997056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
    Maki DG; Ash SR; Winger RK; Lavin P;
    Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R; Adelt M; Chrul S
    Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
    Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
    J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing catheter-related infections in children undergoing hemodialysis.
    Stefanidis CJ
    Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1239-49. PubMed ID: 21073289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter outcomes in the short-term inpatient setting: a controlled quality improvement study comparing citrate and heparin lock.
    Parikh S; Nijmeh R; Van Cleef S; Timmerman S; Bhatt UY; Agarwal AK
    Semin Dial; 2012 May; 25(3):351-6. PubMed ID: 22074231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.